Treatment with metoprolol ameliorated decreased intracellular visfatin activity in cardiomyocytes [33], while Skoczylas et al. observed significant reductions in plasma visfatin levels compared to baseline values after 6 weeks of treatment with bisoprolol in patients with essential hypertension [19]. This evidence concerns the gene NAMPT and hypertensive disorder.